APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Diagnostics Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Diagnostics Service Industry Growth and Trends Forecast to 2032

Report ID 17408507012 January 2026104 pages

Choose your research edition.

Industry ResearchCancer Diagnostics Service Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Diagnostics Service Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Cancer Diagnostics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Diagnostics Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Diagnostics Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Cancer Diagnostics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cancer Diagnostics Service market include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Diagnostics Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Diagnostics Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Diagnostics Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Diagnostics Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cancer Diagnostics Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Diagnostics Service Market by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

Abbott

QIAGEN

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

Applied DNA Sciences

Cancer Diagnostics Service Segment by Type

Breast Cancer

Blood Cancer

Lung Cancer

Colorectal Cancer

Ovarian Cancer

Others

Cancer Diagnostics Service Segment by Application

Hospitals

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

Cancer Diagnostics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Diagnostics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Diagnostics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Diagnostics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cancer Diagnostics Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Diagnostics Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cancer Diagnostics Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cancer Diagnostics Service Market Share by Region (2021-2026) Table 4. Global Cancer Diagnostics Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cancer Diagnostics Service Market Share by Region (2027-2032) Table 6. Global Cancer Diagnostics Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cancer Diagnostics Service Market Size Share by Type (2021-2026) Table 9. Global Cancer Diagnostics Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cancer Diagnostics Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cancer Diagnostics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cancer Diagnostics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cancer Diagnostics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cancer Diagnostics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cancer Diagnostics Service Market Size Share by Application (2021-2026) Table 24. Global Cancer Diagnostics Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cancer Diagnostics Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cancer Diagnostics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cancer Diagnostics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cancer Diagnostics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cancer Diagnostics Service Industry Trends Table 37. Cancer Diagnostics Service Industry Drivers Table 38. Cancer Diagnostics Service Industry Opportunities and Challenges Table 39. Cancer Diagnostics Service Industry Restraints Table 40. Global Cancer Diagnostics Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cancer Diagnostics Service Revenue Market Share by Company (2021-2026) Table 42. Global Cancer Diagnostics Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cancer Diagnostics Service Key Company Headquarters & Area Served Table 44. Global Cancer Diagnostics Service Company, Product Type & Application Table 45. Global Cancer Diagnostics Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cancer Diagnostics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Illumina Cancer Diagnostics Service Product Portfolio Table 52. Illumina Recent Development Table 53. BGI Genomics Co.,Ltd. Company Information Table 54. BGI Genomics Co.,Ltd. Business Overview Table 55. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Portfolio Table 57. BGI Genomics Co.,Ltd. Recent Development Table 58. Agilent Technologies Company Information Table 59. Agilent Technologies Business Overview Table 60. Agilent Technologies Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Agilent Technologies Cancer Diagnostics Service Product Portfolio Table 62. Agilent Technologies Recent Development Table 63. Macrogen Company Information Table 64. Macrogen Business Overview Table 65. Macrogen Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Macrogen Cancer Diagnostics Service Product Portfolio Table 67. Macrogen Recent Development Table 68. Pacific Biosciences Company Information Table 69. Pacific Biosciences Business Overview Table 70. Pacific Biosciences Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pacific Biosciences Cancer Diagnostics Service Product Portfolio Table 72. Pacific Biosciences Recent Development Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Abbott Cancer Diagnostics Service Product Portfolio Table 77. Abbott Recent Development Table 78. QIAGEN Company Information Table 79. QIAGEN Business Overview Table 80. QIAGEN Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. QIAGEN Cancer Diagnostics Service Product Portfolio Table 82. QIAGEN Recent Development Table 83. Siemens Healthcare GmbH Company Information Table 84. Siemens Healthcare GmbH Business Overview Table 85. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Siemens Healthcare GmbH Cancer Diagnostics Service Product Portfolio Table 87. Siemens Healthcare GmbH Recent Development Table 88. Thermo Fisher Scientific, Inc. Company Information Table 89. Thermo Fisher Scientific, Inc. Business Overview Table 90. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Portfolio Table 92. Thermo Fisher Scientific, Inc. Recent Development Table 93. Applied DNA Sciences Company Information Table 94. Applied DNA Sciences Business Overview Table 95. Applied DNA Sciences Cancer Diagnostics Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Applied DNA Sciences Cancer Diagnostics Service Product Portfolio Table 97. Applied DNA Sciences Recent Development Table 98. North America Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Cancer Diagnostics Service Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Cancer Diagnostics Service Market Share by Country (2021-2026) Table 101. North America Cancer Diagnostics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Cancer Diagnostics Service Market Share Forecast by Country (2027-2032) Table 103. Europe Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Cancer Diagnostics Service Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Cancer Diagnostics Service Market Share by Country (2021-2026) Table 106. Europe Cancer Diagnostics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Cancer Diagnostics Service Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Cancer Diagnostics Service Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Cancer Diagnostics Service Market Share by Country (2021-2026) Table 111. Asia-Pacific Cancer Diagnostics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Cancer Diagnostics Service Market Share Forecast by Country (2027-2032) Table 113. Latin America Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Cancer Diagnostics Service Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Cancer Diagnostics Service Market Share by Country (2021-2026) Table 116. Latin America Cancer Diagnostics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Cancer Diagnostics Service Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2021-2026) Table 121. Middle East & Africa Cancer Diagnostics Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Cancer Diagnostics Service Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cancer Diagnostics Service Product Image Figure 3. Global Cancer Diagnostics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Cancer Diagnostics Service Market Share by Region: 2025 VS 2032 Figure 6. Global Cancer Diagnostics Service Market Share by Region (2021-2032) Figure 7. North America Cancer Diagnostics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cancer Diagnostics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cancer Diagnostics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Breast Cancer Image Figure 13. Global Breast Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Blood Cancer Image Figure 15. Global Blood Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Lung Cancer Image Figure 17. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Colorectal Cancer Image Figure 19. Global Colorectal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Ovarian Cancer Image Figure 21. Global Ovarian Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Cancer Diagnostics Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Cancer Diagnostics Service Market Share by Type 2025 VS 2032 Figure 26. North America Cancer Diagnostics Service Market Size Share by Type (2021-2032) Figure 27. Europe Cancer Diagnostics Service Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Cancer Diagnostics Service Market Size Share by Type (2021-2032) Figure 29. Latin America Cancer Diagnostics Service Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Cancer Diagnostics Service Market Size Share by Type (2021-2032) Figure 31. Hospitals Image Figure 32. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Ambulatory Surgical Centers Image Figure 34. Global Ambulatory Surgical Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Diagnostic Laboratories Image Figure 36. Global Diagnostic Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Cancer Diagnostics Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Cancer Diagnostics Service Market Share by Application 2025 VS 2032 Figure 41. North America Cancer Diagnostics Service Market Size Share by Application (2021-2032) Figure 42. Europe Cancer Diagnostics Service Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Cancer Diagnostics Service Market Size Share by Application (2021-2032) Figure 44. Latin America Cancer Diagnostics Service Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Cancer Diagnostics Service Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Cancer Diagnostics Service Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Cancer Diagnostics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Cancer Diagnostics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 51. Europe Cancer Diagnostics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Cancer Diagnostics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 54. Asia-Pacific Cancer Diagnostics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Cancer Diagnostics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 57. Latin America Cancer Diagnostics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cancer Diagnostics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 60. Middle East & Africa Cancer Diagnostics Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Cancer Diagnostics Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • Abbott
  • QIAGEN
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Applied DNA Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cancer Diagnostics Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cancer Diagnostics Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Cancer Diagnostics Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Cancer Diagnostics Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cancer Diagnostics Service Market Size (2021-2032)
  8. 1.5.1 North America Cancer Diagnostics Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cancer Diagnostics Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cancer Diagnostics Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate (2021-2032)
2 Cancer Diagnostics Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Breast Cancer
  3. 2.1.2 Blood Cancer
  4. 2.1.3 Lung Cancer
  5. 2.1.4 Colorectal Cancer
  6. 2.1.5 Ovarian Cancer
  7. 2.1.6 Others
  8. 2.2 Global Cancer Diagnostics Service Market Size by Type
  9. 2.2.1 Global Cancer Diagnostics Service Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Cancer Diagnostics Service Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Cancer Diagnostics Service Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Cancer Diagnostics Service Market Size by Regions
  13. 2.3.1 North America Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Type (2021-2026)
3 Cancer Diagnostics Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Ambulatory Surgical Centers
  4. 3.1.3 Diagnostic Laboratories
  5. 3.1.4 Others
  6. 3.2 Global Cancer Diagnostics Service Market Size by Application
  7. 3.2.1 Global Cancer Diagnostics Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Cancer Diagnostics Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Cancer Diagnostics Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Cancer Diagnostics Service Market Size by Regions
  11. 3.3.1 North America Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Cancer Diagnostics Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cancer Diagnostics Service Industry Trends
  2. 4.2 Cancer Diagnostics Service Industry Drivers
  3. 4.3 Cancer Diagnostics Service Industry Opportunities and Challenges
  4. 4.4 Cancer Diagnostics Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cancer Diagnostics Service Revenue (2021-2026)
  2. 5.2 Global Cancer Diagnostics Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cancer Diagnostics Service Key Company Headquarters & Area Served
  4. 5.4 Global Cancer Diagnostics Service Company, Product Type & Application
  5. 5.5 Global Cancer Diagnostics Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cancer Diagnostics Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cancer Diagnostics Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cancer Diagnostics Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Illumina Cancer Diagnostics Service Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 BGI Genomics Co.,Ltd.
  8. 6.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 6.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 6.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Portfolio
  12. 6.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Technologies Cancer Diagnostics Service Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Macrogen
  20. 6.4.1 Macrogen Company Information
  21. 6.4.2 Macrogen Business Overview
  22. 6.4.3 Macrogen Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Macrogen Cancer Diagnostics Service Product Portfolio
  24. 6.4.5 Macrogen Recent Developments
  25. 6.5 Pacific Biosciences
  26. 6.5.1 Pacific Biosciences Company Information
  27. 6.5.2 Pacific Biosciences Business Overview
  28. 6.5.3 Pacific Biosciences Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pacific Biosciences Cancer Diagnostics Service Product Portfolio
  30. 6.5.5 Pacific Biosciences Recent Developments
  31. 6.6 Abbott
  32. 6.6.1 Abbott Company Information
  33. 6.6.2 Abbott Business Overview
  34. 6.6.3 Abbott Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Abbott Cancer Diagnostics Service Product Portfolio
  36. 6.6.5 Abbott Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 QIAGEN Cancer Diagnostics Service Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Siemens Healthcare GmbH
  44. 6.8.1 Siemens Healthcare GmbH Company Information
  45. 6.8.2 Siemens Healthcare GmbH Business Overview
  46. 6.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Product Portfolio
  48. 6.8.5 Siemens Healthcare GmbH Recent Developments
  49. 6.9 Thermo Fisher Scientific, Inc.
  50. 6.9.1 Thermo Fisher Scientific, Inc. Company Information
  51. 6.9.2 Thermo Fisher Scientific, Inc. Business Overview
  52. 6.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Portfolio
  54. 6.9.5 Thermo Fisher Scientific, Inc. Recent Developments
  55. 6.10 Applied DNA Sciences
  56. 6.10.1 Applied DNA Sciences Company Information
  57. 6.10.2 Applied DNA Sciences Business Overview
  58. 6.10.3 Applied DNA Sciences Cancer Diagnostics Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Applied DNA Sciences Cancer Diagnostics Service Product Portfolio
  60. 6.10.5 Applied DNA Sciences Recent Developments
7 North America
  1. 7.1 North America Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cancer Diagnostics Service Market Size by Country (2021-2026)
  3. 7.3 North America Cancer Diagnostics Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cancer Diagnostics Service Market Size by Country (2021-2026)
  3. 8.3 Europe Cancer Diagnostics Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cancer Diagnostics Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cancer Diagnostics Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cancer Diagnostics Service Market Size by Country (2021-2026)
  3. 10.3 South America Cancer Diagnostics Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cancer Diagnostics Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst